Try Alerts Free   |   Login

Sonoma Pharmaceuticals (SNOA) Financials and Smart Investor 13F Alerts

Health Care, Pharmaceutical Preparations

Data imported from SEC filings and provided as-is without any warranty. Check Sonoma Pharmaceuticals Inc filings before making any investment decision.

SNOA stock chart compared to Revenue:

SNOA Income Statement

Revenue, Net:5769000
Cost of Goods and Services Sold:3267000
Gross Profit:2502000
Selling, General and Administrative Expense:2418000
Research and Development Expense:-85000
Total Operating Expenses:2333000
Operating Income:169000
Net Income (Loss) Attributable to Parent:120000
Earnings Per Share, Diluted:0.07
Earnings Per Share, Basic:0.08
Weighted Average Number of Shares Outstanding, Basic:2043075
Weighted Average Number of Shares Outstanding, Diluted:2159000

SNOA Cash Flow

Depreciation, Depletion and Amortization:54000
Change in Accounts Receiveable:null
Net Cash from Operations:-357000
Net Cash from Financing Activities:213000
Payments to Acquire Property, Plant, and Equipment:45000
Net Cash from Investing Activities:-79000
Net Change in Cash and Cash Equivalents:-231000

SNOA Balance Sheet

Cash and Cash Equivalents:4320000
Accounts Receivable, Net:5279000
Total Current Assets:16267000
Property, Plant and Equipment, Net:370000
Other Long-Term Assets:104000
Total Assets:18145000
Accounts Payable:3202000
Current Portion of Long-Term Debt:49000
Total Short-Term Liabilities:4569000
Long Term Debt, Non-Current Portion:1310000
Total Liabilities:6583000